论文部分内容阅读
目的观察肺癌采用中西医结合治疗的临床效果,为中西医结合治疗肺癌提供科学理论基础。方法选择太和县中医院2011年1月至2013年3月收治的86例肺癌患者为本次研究对象,采用数字奇偶法分为对照组与观察组两组,每组43例。对照组采用常规西医顺铂治疗,观察组在对照组西医治疗基础上给予中医辨证治疗,两组患者均进行为期2个月的治疗,比较两组患者临床疗效及其不良反应。结果治疗后,两组患者病情均得到有效改善,观察组与对照组治疗总有效率分别为93.02%、72.09%,组间比较差异有统计学意义(χ2=15.2727,P=0.0001);观察组患者不良反应发生率为20.93%,明显低于对照组的69.77%(χ2=48.4121,P<0.0001)。结论中西医结合治疗肺癌疗效显著,能够有效降低西医治疗过程中的不良反应,延长患者生存期,提高生命质量,值得在临床上推广与应用。
Objective To observe the clinical effect of combined treatment of Chinese and Western medicine on lung cancer and to provide a scientific basis for the treatment of lung cancer with integrated traditional Chinese and western medicine. Methods Eighty-six patients with lung cancer who were treated in Taihe Hospital of Traditional Chinese Medicine from January 2011 to March 2013 were selected as the study subjects. They were divided into control group and observation group by digital parity method, with 43 cases in each group. The control group was treated with conventional western medicine and cisplatin. The observation group was treated with traditional Chinese medicine in the control group on the basis of western medicine treatment. Both groups were treated for 2 months. The clinical efficacy and adverse reactions of the two groups were compared. Results After treatment, the two groups of patients were effectively treated. The total effective rates of the observation group and the control group were 93.02% and 72.09%, respectively, with significant differences between the two groups (χ2 = 15.2727, P = 0.0001) The incidence of adverse reactions in patients was 20.93%, significantly lower than 69.77% in the control group (χ2 = 48.4121, P <0.0001). Conclusion Integrative treatment of lung cancer significant effect, can effectively reduce the adverse reactions during the treatment of Western medicine to extend the survival of patients and improve the quality of life, it is worth in the clinical promotion and application.